Price$13.37-6.76 (-33.58%)
2026-03-162026-06-17
News · 26 weeks35+167%
2025-12-212026-06-14
Mix2390d
- Insider17(74%)
- Other3(13%)
- SEC Filings3(13%)
Latest news
25 items- INSIDERChief Financial Officer Lin Peter Kuan-How converted options into 10,000 units of CLASS A ORDINARY SHARES and covered exercise/tax liability with 3,588 units of CLASS A ORDINARY SHARES, increasing direct ownership by 40% to 22,312 units (SEC Form 4)4 - Apollomics Inc. (0001944885) (Issuer)
- INSIDERChief Executive Officer Chen Hung-Wen converted options into 5,000 units of CLASS A ORDINARY SHARES, increasing direct ownership by 3% to 148,334 units (SEC Form 4)4 - Apollomics Inc. (0001944885) (Issuer)
- INSIDERDirector Chu Yi-An converted options into 500 units of CLASS A ORDINARY SHARES, increasing direct ownership by 50% to 1,500 units (SEC Form 4)4 - Apollomics Inc. (0001944885) (Issuer)
- INSIDERDirector Chen Hong-Jung converted options into 500 units of CLASS A ORDINARY SHARES, increasing direct ownership by 16% to 3,620 units (SEC Form 4)4 - Apollomics Inc. (0001944885) (Issuer)
- INSIDERDirector Tsai Hsien-Shu converted options into 500 units of CLASS A ORDINARY SHARES, increasing direct ownership by 50% to 1,500 units (SEC Form 4)4 - Apollomics Inc. (0001944885) (Issuer)
- INSIDERChief Operating Officer Chen Yi-Kuei converted options into 5,000 units of CLASS A ORDINARY SHARES, increasing direct ownership by 50% to 15,000 units (SEC Form 4)4 - Apollomics Inc. (0001944885) (Issuer)
- INSIDERDirector Jan Chen-Huan converted options into 500 units of CLASS A ORDINARY SHARES, increasing direct ownership by 50% to 1,500 units (SEC Form 4)4 - Apollomics Inc. (0001944885) (Issuer)
- SECSEC Form EFFECT filed by Apollomics Inc.EFFECT - Apollomics Inc. (0001944885) (Filer)
- INSIDERDirector Huang Ya-Chi converted options into 500 units of CLASS A ORDINARY SHARES, increasing direct ownership by 100% to 1,000 units (SEC Form 4)4 - Apollomics Inc. (0001944885) (Issuer)
- SECAmendment: SEC Form F-3/A filed by Apollomics Inc.F-3/A - Apollomics Inc. (0001944885) (Filer)
- SECSEC Form 6-K filed by Apollomics Inc.6-K - Apollomics Inc. (0001944885) (Filer)
- SECSEC Form 20-F filed by Apollomics Inc.20-F - Apollomics Inc. (0001944885) (Filer)
- INSIDERAmendment: SEC Form 3 filed by new insider Chen Hong-Jung3/A - Apollomics Inc. (0001944885) (Issuer)
- INSIDERSEC Form 4 filed by Lin Peter Kuan-How4 - Apollomics Inc. (0001944885) (Issuer)
- INSIDERAmendment: SEC Form 3 filed by new insider Jan Chen-Huan3/A - Apollomics Inc. (0001944885) (Issuer)
- INSIDERAmendment: SEC Form 3 filed by new insider Tsai Hsien-Shu3/A - Apollomics Inc. (0001944885) (Issuer)
- INSIDERAmendment: SEC Form 3 filed by new insider Lin Peter Kuan-How3/A - Apollomics Inc. (0001944885) (Issuer)
- INSIDERAmendment: SEC Form 3 filed by new insider Chen Hung-Wen3/A - Apollomics Inc. (0001944885) (Issuer)
- INSIDERAmendment: SEC Form 3 filed by new insider Chu Yi-An3/A - Apollomics Inc. (0001944885) (Issuer)
- INSIDERAmendment: SEC Form 3 filed by new insider Chen Yi-Kuei3/A - Apollomics Inc. (0001944885) (Issuer)
- INSIDERAmendment: SEC Form 3 filed by new insider Huang Ya-Chi3/A - Apollomics Inc. (0001944885) (Issuer)
- SECSEC Form 6-K filed by Apollomics Inc.6-K - Apollomics Inc. (0001944885) (Filer)
- PRApollomics Inc. Announces $2.0 Million Bridge FinancingFOSTER CITY, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), today announced that it has entered into a $2.0 million unsecured Convertible Promissory Note (the "Note") with Mr. Hung-Wen (Howard) Chen, the Company's Chairman and Chief Executive Officer, on March 30, 2026. The $2.0 million in proceeds from the Note are intended to provide the Company with necessary working capital to support clinical development programs and general corporate operations. The Note is an unsecured obligation of the Company and carries a 0% interest rate. Under the terms of the agreement, the principal amount will automatically convert into equity secu
- INSIDERSEC Form 3 filed by new insider Chen Hung-Wen3 - Apollomics Inc. (0001944885) (Issuer)
- INSIDERSEC Form 3 filed by new insider Chen Hong-Jung3 - Apollomics Inc. (0001944885) (Issuer)
APLM FAQ
4 questionsWhere does APLM stock trade?
Apollomics Inc. (APLM) is listed on NASDAQ.What sector and industry is APLM in?
Apollomics Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What companies are similar to APLM?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare APLM side-by-side with any of them on Quantisnow.How can I track APLM on Quantisnow?
Quantisnow aggregates Apollomics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow APLM to receive live email and push alerts on every new disclosure.